These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 27267309)

  • 1. Access to HIV treatment and care for people who inject drugs in Kenya: a short report.
    Guise A; Rhodes T; Ndimbii J; Ayon S; Nnaji O
    AIDS Care; 2016 Dec; 28(12):1595-1599. PubMed ID: 27267309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and facilitators of access to HIV, harm reduction and sexual and reproductive health services by women who inject drugs: role of community-based outreach and drop-in centers.
    Ayon S; Ndimbii J; Jeneby F; Abdulrahman T; Mlewa O; Wang B; Ragi A; Mburu G
    AIDS Care; 2018 Apr; 30(4):480-487. PubMed ID: 29067855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generating trust: Programmatic strategies to reach women who inject drugs with harm reduction services in Dar es Salaam, Tanzania.
    Zamudio-Haas S; Mahenge B; Saleem H; Mbwambo J; Lambdin BH
    Int J Drug Policy; 2016 Apr; 30():43-51. PubMed ID: 26880500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators.
    Ludwig-Barron NT; Guthrie BL; Mbogo L; Bukusi D; Sinkele W; Gitau E; Farquhar C; Monroe-Wise A
    Harm Reduct J; 2021 Dec; 18(1):133. PubMed ID: 34922548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Client and Provider Perspectives on Antiretroviral Treatment Uptake and Adherence Among People Who Inject Drugs in Indonesia, Ukraine and Vietnam: HPTN 074.
    Go VF; Hershow RB; Kiriazova T; Sarasvita R; Bui Q; Latkin CA; Rose S; Hamilton E; Lancaster KE; Metzger D; Hoffman IF; Miller WC
    AIDS Behav; 2019 Apr; 23(4):1084-1093. PubMed ID: 30306437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to and acceptability of sexual and reproductive health, harm reduction and other essential health services among people who inject drugs in Durban, South Africa.
    Milford C; Cavanagh T; Bosman S; Wilson M; Smit J; Zanoni B
    Harm Reduct J; 2024 Jun; 21(1):123. PubMed ID: 38926755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study.
    Kiriazova T; Go VF; Hershow RB; Hamilton EL; Sarasvita R; Bui Q; Lancaster KE; Dumchev K; Hoffman IF; Miller WC; Latkin CA
    Harm Reduct J; 2020 Oct; 17(1):69. PubMed ID: 32998731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes towards people living with HIV and people who inject drugs: A mixed method study of stigmas within harm reduction programs in Kazakhstan.
    Stringer KL; Mukherjee T; McCrimmon T; Terlikbayeva A; Primbetovac S; Darisheva M; Hunt T; Gilbert L; El-Bassel N
    Int J Drug Policy; 2019 Jun; 68():27-36. PubMed ID: 30981165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to and use of health and social services among people who inject drugs in two urban areas of Mozambique, 2014: qualitative results from a formative assessment.
    Dengo-Baloi L; Boothe M; Semá Baltazar C; Sathane I; Langa DC; Condula M; Ricardo H; Inguane C; Teodoro E; Gouveia L; Raymond HF; Horth R
    BMC Public Health; 2020 Jun; 20(1):975. PubMed ID: 32571365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Who has ever loved a drug addict? It's a lie. They think a 'teja' is as bad person": multiple stigmas faced by women who inject drugs in coastal Kenya.
    Mburu G; Ayon S; Tsai AC; Ndimbii J; Wang B; Strathdee S; Seeley J
    Harm Reduct J; 2018 May; 15(1):29. PubMed ID: 29801494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding conceptualizations of harm reduction: results from a qualitative community-based participatory research study with people who inject drugs.
    Boucher LM; Marshall Z; Martin A; Larose-Hébert K; Flynn JV; Lalonde C; Pineau D; Bigelow J; Rose T; Chase R; Boyd R; Tyndall M; Kendall C
    Harm Reduct J; 2017 May; 14(1):18. PubMed ID: 28494774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A qualitative analysis of transitions to heroin injection in Kenya: implications for HIV prevention and harm reduction.
    Guise A; Dimova M; Ndimbii J; Clark P; Rhodes T
    Harm Reduct J; 2015 Sep; 12():27. PubMed ID: 26337729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving access to HIV care among people who inject drugs through tele-harm reduction: a qualitative analysis of perceived discrimination and stigma.
    Scaramutti C; Hervera B; Rivera Y; Chueng TA; Forrest DW; Suarez E; Serota DP; Alkamli H; Ciraldo K; Bartholomew TS; Tookes HE
    Harm Reduct J; 2024 Feb; 21(1):50. PubMed ID: 38396017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health Provider Views on Improving Antiretroviral Therapy Adherence Among Men Who Have Sex with Men in Coastal Kenya.
    Micheni M; Kombo BK; Secor A; Simoni JM; Operario D; van der Elst EM; Mugo P; Kanungi J; Sanders EJ; Graham SM
    AIDS Patient Care STDS; 2017 Mar; 31(3):113-121. PubMed ID: 28282249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "They don't like us….": Barriers to antiretroviral and opioid substitution therapy among homeless HIV positive people who inject drugs in Delhi: A mixed method study.
    Kumar S; Gupte HA; Isaakidis P; Mishra JK; Munjattu JF
    PLoS One; 2018; 13(8):e0203262. PubMed ID: 30161255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical Providers and Harm Reduction Views on Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
    Hershow RB; Gonzalez M; Costenbader E; Zule W; Golin C; Brinkley-Rubinstein L
    AIDS Educ Prev; 2019 Aug; 31(4):363-379. PubMed ID: 31361517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tale of two Badakhshans: Determinants of access and utilization of HIV preventive services along the Afghan-Tajik border.
    Sidhu H; Gebreweldi F; Davis A; Jonbekov J; Bahramov M; Dasgupta A; McCrimmon T; Marotta P; Dehghani K
    Int J STD AIDS; 2024 Nov; 35(13):1025-1031. PubMed ID: 39193843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of needle and syringe program services in the Kyrgyz Republic: Key barriers and facilitators.
    Deryabina A; El-Sadr WM
    Drug Alcohol Depend; 2017 Oct; 179():180-186. PubMed ID: 28787695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
    Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
    Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupational roles and risks of community-embedded peer educators providing HIV, hepatitis C and harm reduction services to persons who inject drugs in Nairobi, Kenya.
    Masese LN; Ludwig-Barron NT; Mbogo L; Guthrie BL; Musyoki H; Bukusi D; Sinkele W; Gitau E; Farquhar C; Monroe-Wise A
    PLoS One; 2022; 17(12):e0278210. PubMed ID: 36454881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.